Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Nov. 30, 2019 |
Nov. 30, 2018 |
Nov. 30, 2019 |
Nov. 30, 2018 |
|
| Income Statement [Abstract] | ||||
| Revenue | $ 0 | $ 0 | $ 0 | $ 0 |
| Operating Expenses | ||||
| Research and development, net (Note 12) | 1,278,172 | 792,111 | 3,246,246 | 2,924,483 |
| General and administrative (Note 12) | 1,825,813 | 1,971,847 | 5,447,056 | 6,721,796 |
| Depreciation and amortization (Notes 4 and 5) | 219,628 | 155,053 | 585,367 | 366,710 |
| Interest and other finance costs (Note 15) | 693,027 | 14,883 | 1,817,091 | 41,117 |
| Interest income | (171,274) | 0 | (363,565) | 0 |
| Foreign exchange loss (gain) | 5,533 | (20,132) | 15,297 | (72,404) |
| Total expenses | 3,850,899 | 2,913,762 | 10,747,492 | 9,981,702 |
| Net loss | (3,850,899) | (2,913,762) | (10,747,492) | (9,981,702) |
| Other comprehensive loss | ||||
| Foreign currency translation adjustment | 7,552 | (91,249) | (30,133) | (202,838) |
| Comprehensive loss | $ (3,843,347) | $ (3,005,011) | $ (10,777,625) | $ (10,184,540) |
| Loss per share | ||||
| Basic and diluted | $ (.10) | $ (0.09) | $ (0.29) | $ (.30) |
| Weighted average common shares outstanding | ||||
| Basic and diluted | 39,133,627 | 33,805,706 | 37,404,165 | 33,792,293 |